GE HealthCare Technologies Inc. which can be found using ticker (GEHC) now have 13 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The target price High/Low ranges between $110.00 and $86.00 suggesting an average Analsyt target price of $95.71. Now with the previous closing price of $84.49 and the analysts are correct then there would likely be a percentage uptick in value of 13.3%. The 50 day MA is $88.51 while the 200 day moving average is $76.10. The company has a market cap of 38.47B. The stock price for the company is currently $84.31 USD
The potential market cap would be $43,582,103,231 based on the market consensus.
The company has a dividend yield of 0.77%. Other points of data to note are a P/E ratio of 27.73, revenue per share of $42.97 and a 6.15% return on assets.
GE HealthCare Technologies Inc. is a global medical technology, pharmaceutical diagnostics, and digital solutions company. The Company develops, manufactures, and markets a portfolio of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients. The Company’s segments include Imaging, Ultrasound, Patient Care Solutions and Pharmaceutical Diagnostics. The Imaging segment includes scanning devices, clinical applications, service capabilities and digital solutions. The Ultrasound segment includes screening, diagnosis, treatment, and monitoring of certain diseases. The Patient Care Solutions segment includes medical devices, services, consumable products, services, and digital solutions. The Pharmaceutical Diagnostics segment is a supplier of diagnostic agents to the global radiology and nuclear medicine industry.
